Skip to content

Precise design and clinical observation of posterior scleral reinforcement surgery

Precise design and clinical observation of posterior scleral reinforcement surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073573
Enrollment
Unknown
Registered
2023-07-14
Start date
2023-07-13
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pathologic myopia

Interventions

Precision design group :posterior scleral reinforcement surgery based on precise design
Traditional surgical team :Traditional classic posterior scleral reinforcement surgery

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: The patient visited our hospital and was diagnosed with pathological myopia, requiring scleral reinforcement surgery. 2: The patient meets one of the following criteria: a. Aged 5-7, myopia refractive power greater than 5.0D at age 5, greater than 6D at age 6, and greater than 7D at age 7 3: b. Aged 8-17, myopia refractive power greater than 6D, with an annual increase in myopia refractive power greater than 1D and an eye axial elongation greater than 0.4mm 4: c. Aged 18 or older, with scleral granuloma combined with myopia-induced traction maculopathy.

Exclusion criteria

Exclusion criteria: 1: History of definite trauma and ocular surgery, significantly affecting surgical procedures 2: inability to tolerate general anesthesia 3: preterm birth and other abnormal birth histories 4: presence of conditions such as keratoconus, corneal opacity, ptosis 5: other exclusion criteria as determined by the researcher

Design outcomes

Primary

MeasureTime frame
Refractive power ;Corrected vision;axial length ;

Countries

China

Contacts

Public ContactWei Ruihua

Tianjin Medical University Eye Hospital

rwei@tmu.edu.cn+86 139 2068 5016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026